Get started
Work

Supplementary Figure S3 from Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S3. Treatment regimens for each patient, with relapse designated day 0.
DOI: 10.1158/1078-0432.22457765.v1
Authors: Christine E. Brown, Behnam Badie, Michael E. Barish, Lihong Weng, Julie R. Ostberg, Wen-Chung Chang, Araceli Naranjo, Renate Starr, Jamie Wagner, Christine Wright, Yubo Zhai, James R. Bading, Julie A. Ressler, Jana Portnow, Massimo D'Apuzzo, Stephen J. Forman, Michael C. Jensen
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361916612
Cites:
Cited by:
Related to: 10